ImmunoPrecise Antibodies

March 19, 2020

Hope replaces hype for coronavirus stocks

Investors are homing in on biopharma companies able to make real contributions to the coronavirus pandemic, but market frothiness is far from over.

March 05, 2020

Biopharma’s role in tackling coronavirus

The industry has a duty to develop Covid-19 antivirals and vaccines, but the nature of clinical trials means that lower-profile measures must take precedence.

February 27, 2020

Coronavirus stock hype proves infectious

Coronavirus-focused investors have willingly backed bona fide development and egregious publicity stunts alike.

ImmunoPrecise Antibodies

Hope replaces hype for coronavirus stocks

Biopharma’s role in tackling coronavirus

Coronavirus stock hype proves infectious

Latest Reports

Evaluate Vantage Pharma, Biotech & Medtech 2020 in Review

Evaluate Vantage 2021 Preview

Editor's Picks

AACR 2021 preview – the early themes emerge

Big pharma’s key catalysts in the second quarter

A busy year ahead for Parkinson’s disease

Frequency refuses to hear the death knell

The reckoning begins for biotech-focused Spacs